Industry Event
Hamamatsu Overview of Current and Future Technologies for Medical Point of Care Diagnostics
icon_in-person.svgIn person: 29 September 2021 • 10:50 AM - 11:10 AM BST | Exhibition Hall 4, Industry Stage 
Hamamatsu Overview of Current and Future Technologies for Medical Point of Care Diagnostics


Kevin McKechnie, Hamamatsu Photonics UK Ltd. (United Kingdom)

From Cancer to Covid, early diagnosis is vital for patient outcomes. With cutting edge technology it is possible to perform a wide variety of diagnostic processes at the point of care, thus reducing the time taken for test results to be returned and also to increase the frequency of these critical tests. Join Hamamatsu to hear about some of these current and future technologies, what they mean to the medical diagnostic industry and also what could be coming in the future.

Kevin McKechnie graduated from the University of Strathclyde in 2018 with a Master’s degree in Physics and joined Hamamatsu shortly after. Fast forward to the present and Kevin is now a member of Hamamatsu’s Medical & Analytical Group focusing on sales and business development activities in these key application areas for Hamamatsu UK.